

A startup aiming to supply genetically enhanced working dogs to the United States military and law enforcement raised US$200 million to deliver on plans conceived by Palmer Luckey, co-founder of Anduril Industries Inc., and biotech entrepreneur Ben Lamm.
Subscribe now to read the latest news in your city and across Canada.
- Exclusive articles from Barbara Shecter, Joe O'Connor, Gabriel Friedman, and others.
- Daily content from Financial Times, the world's leading global business publication.
- Unlimited online access to read articles from Financial Post, National Post and 15 news sites across Canada with one account.
- National Post ePaper, an electronic replica of the print edition to view on any device, share and comment on.
- Daily puzzles, including the New York Times Crossword.
Subscribe now to read the latest news in your city and across Canada.
- Exclusive articles from Barbara Shecter, Joe O'Connor, Gabriel Friedman and others.
- Daily content from Financial Times, the world's leading global business publication.
- Unlimited online access to read articles from Financial Post, National Post and 15 news sites across Canada with one account.
- National Post ePaper, an electronic replica of the print edition to view on any device, share and comment on.
- Daily puzzles, including the New York Times Crossword.
Create an account or sign in to continue with your reading experience.
- Access articles from across Canada with one account.
- Share your thoughts and join the conversation in the comments.
- Enjoy additional articles per month.
- Get email updates from your favourite authors.
Create an account or sign in to continue with your reading experience.
- Access articles from across Canada with one account
- Share your thoughts and join the conversation in the comments
- Enjoy additional articles per month
- Get email updates from your favourite authors
Sign In or Create an Account
Texas-based Warhound has backing from investors including In-Q-Tel Inc., Sequoia Capital and ARK Investment Management LLC, the company said in a statement Thursday. Warhound intends to use innovations in genetics, cloning and biology to enhance the quality of working animals and reduce dependence on Europe, currently the source of 80 per cent of U.S. military dogs, it said.
“They detect explosives, protect our troops, and run toward dangers that most people are trained to run away from,” said Lamm, chief executive of Colossal Biosciences Inc. “Yet we’re still relying on outdated approaches to breeding and training these extraordinary animals.”
Get the latest headlines, breaking news and columns.
By signing up you consent to receive the above newsletter from Postmedia Network Inc.
A welcome email is on its way. If you don't see it, please check your junk folder.
The next issue of Top Stories will soon be in your inbox.
We encountered an issue signing you up. Please try again
Lamm, who will serve on Warhound’s board, and Luckey developed the idea for a company to tackle reliance on overseas breeders and to address the fact that about half of candidate dogs fail military training, Warhound said. Luckey has no ongoing role or equity in the startup.
The U.S. has about 1,600 working military dogs and currently breeds about 13 per cent of canine recruits through a program at Joint Base San Antonio, according to the Department of Defense.
Warhound will use expertise from Colossal, which is working to recreate extinct animals including the dodo, to produce healthier dogs better suited to demanding missions, the company said. Dogs and handlers will be equipped with Anduril technology.
“Working dogs are extraordinary animals whose courage and loyalty save lives,” said Robin Ganzert, president and CEO of the American Humane Society, which will help guide the startup. “We owe these dogs a commitment to their well-being that matches their service to us.”
Join the Conversation
This website uses cookies to personalize your content (including ads), and allows us to analyze our traffic. Read more about cookies here. By continuing to use our site, you agree to our Terms of Use and Privacy Policy.
